Arthritis clinical trials at UCSF
11 in progress, 5 open to eligible people
Biofeedback Retention in Individuals With AKA
open to eligible people ages 18-70
More than two million Americans are currently living with a full or partial limb loss, and an additional 185,000 amputations occur each year. The majority of amputations occur in the lower limbs. There are many potential causes for amputation, but…
San Francisco, California and other locations
Rheumatoid Arthritis Shared Decision Making
open to eligible people ages 18 years and up
Shared decision making is the first overarching principle for the treat to target guidelines for rheumatoid arthritis (RA) and has been proposed as a potential mechanism to reduce health disparities, however there is little evidence to inform…
San Francisco, California and other locations
Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
open to eligible people ages 18-70
This study will test the safety and effects of SBT777101 when given as a single dose to subjects with rheumatoid arthritis. It is the first study of this treatment being done in humans. Increasing dose levels will be given after the safety at lower…
San Francisco, California and other locations
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
open to eligible people ages 18-90
A study to identify patients with Rheumatoid Arthritis - Associated Interstitial Lung Disease (RA-ILD) that are at the highest risk for progression. The goal of the investigators is to recruit a group of patients with RA-ILD and collect information…
San Francisco, California and other locations
Shoulder ID™ Primary Reversed Glenoid Outcomes Clinical Study
open to eligible people ages 18 years and up
The goal of the Shoulder iD™ Primary Reversed Glenoid Outcomes Clinical Study is to collect safety and performance data on the commercially available Shoulder iD™ Primary Reversed Glenoid device. The study will learn about standard device use in…
San Francisco, California and other locations
Zr-89 Cimzia PET Imaging Rheumatoid Arthritis
Sorry, currently not accepting new patients, but might later
This is a single center exploratory imaging study investigating the initial application of zirconium-89 Deferoxamine B Certolizumab pegol (89Zr-DFO-CZP) PET in patients with rheumatoid arthritis. Patients with active symptoms of RA or signs on…
San Francisco, California
Adalimumab in JIA-associated Uveitis Stopping Trial
Sorry, in progress, not accepting new patients
The proposed study is a stratified, block-randomized, double-masked, controlled trial to determine the feasibility of discontinuing adalimumab treatment in patients with quiescent uveitis associated with juvenile idiopathic arthritis (JIA) or…
San Francisco, California and other locations
CD40L Antagonism in Rheumatoid Arthritis (RA)
Sorry, not currently recruiting here
The primary objective is to determine if the addition of a 12-week course of treatment with VIB4920 to TNFi treatment will result in improved clinical disease control in patients with RA who have had an inadequate response to a TNFi.
San Francisco, California and other locations
Insignia™ Hip Stem Outcomes Study
Sorry, in progress, not accepting new patients
The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.
San Francisco, California and other locations
Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System
Sorry, accepting new patients by invitation only
A Multi-Center Study in Patients Undergoing Total Hip Arthroplasty with the Smith+Nephew CATALYSTEM™ Primary Hip System. The purpose of the study is to assess safety and performance of the CATALYSTEM™ and to support product approval in global…
San Francisco, California and other locations
Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System
Sorry, in progress, not accepting new patients
The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.
San Francisco, California and other locations
Our lead scientists for Arthritis research studies include Nisha Acharya Jonathan Graf Richard Souza Robert Flavell, MD, PhD Erik Hansen.
Last updated: